News | December 09, 2014

vRad Expands Investments in its Breast Imaging Program

Fellowship-trained breast imaging specialist to oversee ACR/MQSA-compliant program that provides lead interpreting physician services

teleradiology, mammography systems, women's health, RSNA 2014

Image courtesy of Hologic Dimensions

December 9, 2014 — vRad (Virtual Radiologic) announced that  Arlene Sussman, M.D. has been promoted to vRad’s medical leadership team as medical director. Along with providing interpretations, Sussman is responsible for ensuring that the clinical operations of vRad’s mammography services deliver the highest level of service to its clients and the patients they serve. She also will help to recruit and hire additional fellowship-trained breast imaging subspecialists into the practice with expertise in mammography and diagnostic breast services.

As the largest private practice in the country, vRad provides clients nationwide access to board-certified, fellowship-trained mammographers with extensive training and experience in a complete suite of breast imaging services, which include:

·    Full screening and diagnostic mammographic and breast sonographic interpretations.

·   Methods to remain ACR and MQSA-compliant that include lead interpreting physician services, where vRad is assigned responsibility to help ensure that a facility's quality assurance program remains compliant. It will include a quarterly review of the mammography practice, along with ongoing feedback and the necessary reviews to ensure compliance and continued accreditation. This will be a requirement for any situation where vRad is the sole mammography interpreter for a facility.

·  Providing Breast Imaging Reporting and Data System (BIRADS) score reports to clients on a regular basis for easier and more transparent patient tracking. Clients will be able to access BIRADS data at any time via vRad’s Client Access Portal, improving their ability to follow up on suspicious mammogram findings as well as to document the process.

· Flexible program implementation so that vRad’s wide range of expertise can help enhance the level of care by filling any of an imaging staff’s specialty gaps, including breast MRIs, or meeting overflow needs to free the existing radiology team to review other studies or procedures.

For more information: www.vrad.com

 

Related Content

Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
Virtual reality during chemotherapy has been shown to improve breast cancer patients’ quality of life during the most stressful treatments
News | Virtual and Augmented Reality | January 21, 2020
January 21, 2020 — Virtual reality during chemotherapy has been shown to improve...